Qube Research & Technologies (QRT)
BIIB icon

Qube Research & Technologies (QRT)’s Biogen BIIB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9M Sell
15,800
-56,400
-78% -$10.4M ﹤0.01% 1954
2025
Q4 		$12.7M Sell
72,200
-11,000
-13% -$1.8M 0.01% 1185
2025
Q3 		$11.7M Sell
83,200
-20,300
-20% -$2.74M 0.01% 1222
2025
Q2 		$13M Sell
103,500
-6,400
-6% -$797K 0.01% 1139
2025
Q1 		$15M Buy
109,900
+83,800
+321% +$12M 0.02% 886
2024
Q4 		$3.99M Buy
26,100
+10,600
+68% +$1.79M 0.01% 1599
2024
Q3 		$3M Buy
+15,500
New +$3.24M ﹤0.01% 1601
2024
Q2 		– Sell
-100
Closed -$21.6K – 3831
2024
Q1 		$21.6K Buy
+100
New +$23.4K ﹤0.01% 3680
2023
Q4 		– Sell
-18,300
Closed -$4.7M – 4342
2023
Q3 		$4.7M Buy
+18,300
New +$4.89M 0.01% 960

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIIB Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Biogen (BIIB) in Q1 2026: 212,921 shares worth $39M. The stake represents 0.04% of the portfolio and ranks #532 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in BIIB as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in BIIB in Q1 2018 and has held it in 24 quarters since. The position peaked at $168M in Q1 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Qube Research & Technologies (QRT) held 212,921 shares of Biogen worth $39M as of Q1 2026.
  • Biogen was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Biogen made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #532 holding.
  • Qube Research & Technologies (QRT) first reported a position in Biogen in Q1 2018 and has held it in 24 quarters since.
  • Qube Research & Technologies (QRT)'s Biogen position peaked at $168M in Q1 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.